SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

11118	Companies
244800	Keywords
172882	Articles
131991	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 05/31/2024 at 12:05, 2 years 4 months ago

Sanofi Launches 2024 Global Employee Stock Purchase Plan

Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
PRESS RELEASE

published on 05/31/2024 at 12:00, 2 years 4 months ago

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth

Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
BRIEF

published on 05/31/2024 at 07:10, 2 years 4 months ago

CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD

Sanofi COPD Dupixent CHMP Supply
PRESS RELEASE

published on 05/31/2024 at 07:05, 2 years 4 months ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU

Dupixent CHMP EU Approval COPD Treatment Type 2 Inflammation
BRIEF

published on 05/30/2024 at 15:06, 2 years 4 months ago

Sanofi Completes Acquisition of Inhibrx, Inc.

Acquisition Sanofi Rare Diseases Inhibrx SAR447537
PRESS RELEASE

published on 05/30/2024 at 15:01, 2 years 4 months ago

Press Release: Sanofi completes acquisition of Inhibrx, Inc.
Sanofi completes acquisition of Inhibrx, Inc., adding SAR447537 to rare disease pipeline. Former Inhibrx shareholders receive $30.00 per share in cash and one contingent value right. Inhibrx Biosciences begins trading on NASDAQ as INXB

Acquisition Nasdaq Sanofi Inhibrx SAR447537
BRIEF

published on 05/27/2024 at 07:05, 2 years 4 months ago

FDA Grants Priority Review to Sarclisa for Treatment of Multiple Myeloma

FDA Sanofi Multiple Myeloma Sarclisa Chemotherapy
BRIEF

published on 05/21/2024 at 07:35, 2 years 4 months ago

Sanofi, Formation Bio, and OpenAI Announce AI Collaboration

Collaboration AI Drug Development Sanofi OpenAI Formation Bio
PRESS RELEASE

published on 05/21/2024 at 07:30, 2 years 4 months ago

Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Sanofi, Formation Bio, and OpenAI collaborate to accelerate drug development with AI-powered software. The partnership aims to bring new medicines more efficiently

Collaboration Drug Development Sanofi OpenAI Formation Bio
BRIEF

published on 05/20/2024 at 22:59, 2 years 4 months ago

Sanofi: April 2024 Voting Rights and Shares Information

Voting Rights Shares Financial Disclosure April 2024 Sanofi

Accesswire

Published on 10/03/2026 at 02:35, 9 hours 44 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 18 hours 34 minutes ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 22 hours 29 minutes ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 23 hours 19 minutes ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 23 hours 19 minutes ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/02/2026 at 23:55, 12 hours 23 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 15 hours 55 minutes ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 16 hours 32 minutes ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 18 hours 18 minutes ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 18:00, 18 hours 19 minutes ago

AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 18 hours 34 minutes ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 18 hours 49 minutes ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 1 day 17 hours ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 1 day 17 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 1 day 18 hours ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE